End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Cullen
FOU | Founder | 78 | 11-09-20 |
Jennifer Simpson
CEO | Chief Executive Officer | 55 | 20-07-15 |
Susan Horvath
DFI | Director of Finance/CFO | 65 | 18-04-16 |
Tammy Groene
COO | Chief Operating Officer | - | 12-03-31 |
Chief Tech/Sci/R&D Officer | - | 22-05-31 | |
Rachel Bragg
PRN | Corporate Officer/Principal | - | 21-05-31 |
- | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer Simpson
CEO | Chief Executive Officer | 55 | 20-07-15 |
Director/Board Member | 63 | 15-09-29 | |
Michael Cullen
FOU | Founder | 78 | 11-09-20 |
Jeffrey Jacob
BRD | Director/Board Member | 62 | 22-06-14 |
Arthur Fratamico
BRD | Director/Board Member | 58 | 19-12-15 |
Dan Donovan
BRD | Director/Board Member | 59 | 22-06-14 |
Donald Schemel
BRD | Director/Board Member | 68 | 15-09-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,854,882 | 4,854,791 ( 100.00 %) | 21 ( 0.000432 %) | 100.00 % |
Company contact information
Panbela Therapeutics, Inc.
712 Vista Boulevard Suite 305
55387, Waconia
+952 479 1196
http://www.panbela.com1st Jan change | Capi. | |
---|---|---|
+12.64% | 3,096B | |
+12.86% | 85.37B | |
+8.01% | 77.1B | |
-13.71% | 54.31B | |
-22.33% | 47.92B | |
+25.78% | 47.74B | |
+21.97% | 42.15B | |
+70.20% | 38.06B | |
-8.38% | 24.73B |
- Stock Market
- Equities
- Stock
- Company Sun Biopharma Inc